Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 112744063 | 11274406 | 3 | F | 2013 | 20160801 | 20150715 | 20160808 | PER | US-CELGENEUS-USA-2015070243 | CELGENE | 0.00 | M | Y | 63.56000 | KG | 20160808 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 112744063 | 11274406 | 1 | PS | REVLIMID | LENALIDOMIDE | 1 | Oral | N | U | UNKNOWN | 21880 | 15 | MG | CAPSULES | QD | ||||
| 112744063 | 11274406 | 2 | SS | REVLIMID | LENALIDOMIDE | 1 | Oral | 5-15 MG | N | U | UNKNOWN | 21880 | CAPSULES | QD | |||||
| 112744063 | 11274406 | 3 | SS | REVLIMID | LENALIDOMIDE | 1 | Oral | N | U | UNKNOWN | 21880 | 10 | MG | CAPSULES | |||||
| 112744063 | 11274406 | 4 | SS | DEXAMETHASONE. | DEXAMETHASONE | 1 | Unknown | U | U | 0 | UNKNOWN | ||||||||
| 112744063 | 11274406 | 5 | C | ACYCLOVIR. | ACYCLOVIR | 1 | Unknown | 0 | UNKNOWN | ||||||||||
| 112744063 | 11274406 | 6 | C | VELCADE | BORTEZOMIB | 1 | Subcutaneous | 0 | UNKNOWN |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 112744063 | 11274406 | 1 | Plasma cell myeloma |
| 112744063 | 11274406 | 4 | Plasma cell myeloma |
| 112744063 | 11274406 | 5 | Product used for unknown indication |
| 112744063 | 11274406 | 6 | Plasma cell myeloma |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 112744063 | 11274406 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 112744063 | 11274406 | Balance disorder | |
| 112744063 | 11274406 | Cataract | |
| 112744063 | 11274406 | Confusional state | |
| 112744063 | 11274406 | Dizziness | |
| 112744063 | 11274406 | Fatigue | |
| 112744063 | 11274406 | Feeling drunk | |
| 112744063 | 11274406 | Lacrimation increased | |
| 112744063 | 11274406 | Myalgia | |
| 112744063 | 11274406 | Rhinorrhoea | |
| 112744063 | 11274406 | Vision blurred |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 112744063 | 11274406 | 1 | 201305 | 0 | ||
| 112744063 | 11274406 | 2 | 201403 | 0 | ||
| 112744063 | 11274406 | 3 | 201512 | 0 |